Pathophysiology of Ischemia-Reperfusion Injury: New Therapeutic Options for Acute Myocardial Infarction;Fisiopatología del daño miocárdico por isquemia-reperfusión: nuevas oportunidades terapéuticas en el infarto agudo de miocardio

Revista Espanola de Cardiologia

Volumn 62, Issue 2, 2009, Pages 199-209

  Ruiz Meana, Marisol ^a   García Dorado, David ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Calcium; Hypercontracture; Mitochondria; Necrosis

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; ARGININE; ATRIAL NATRIURETIC FACTOR; CALCIUM ION; CARIPORIDE; CYCLOSPORIN A; ENIPORIDE; GUANOSINE PHOSPHATE; PROTEINASE;

ACUTE HEART INFARCTION; ARTICLE; CELL DEATH; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVATION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HUMAN; ISCHEMIA; ISCHEMIA REPERFUSION INJURY; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PATHOPHYSIOLOGY; QUALITY OF LIFE; REPERFUSION INJURY; ACUTE DISEASE; ANIMAL; CELL SIZE; HEART INFARCTION; HEART MUSCLE; NECROSIS; PATHOLOGY; REVIEW;

ACUTE DISEASE; ANIMALS; CELL DEATH; CELL SIZE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NECROSIS;

EID: 60449118491     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70162-9     Document Type: Article

References (58)

1. Foot D.K., Lewis R.P., Pearson T.A., and Beller G.A. Demographics and cardiology, 1950-2050. J Am Coll Cardiol 35 Suppl B (2000) B66-B80
2. Piper H.M., Abdallah Y., and Schäfer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61 (2004) 365-371
3. García-Dorado D., Théroux P., Duran J.M., Solares J., Alonso J., Sanz E., et al. Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 85 (1992) 1160-1174
4. Hearse D.J., Humphrey S.M., and Chain E.B. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 5 (1973) 395-407
5. Vander Heide R.S., Angelo J.P., Altschuld R.A., and Ganote C.E. Energy dependence of contraction band formation in perfused hearts and isolated adult myocytes. Am J Pathol 125 (1986) 55-68
6. Piper H.M., García-Dorado D., and Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 38 (1998) 291-300
7. Barrabés J.A., García-Dorado D., Ruiz-Meana M., Piper H.M., Solares J., González M.A., et al. Myocardial segment shrinkage during coronary reperfusion in situ. Relation to hypercontracture and myocardial necrosis. Pflugers Arch 431 (1996) 519-526
8. Siegmund B., Zude R., and Piper H.M. Recovery of anoxicreoxygenated cardiomyocytes from severe calcium overload. Am J Physiol 263 (1992) H1262-H1269
9. Inserte J., García-Dorado D., Ruiz-Meana M., Padilla F., Barrabés J.A., Pina P., et al. Effect of inhibition of Na(+)/Ca(2+) exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc Res 55 (2002) 739-748
10. García-Dorado D., Théroux P., Munoz R., Alonso J., Elizaga J., Fernandez-Avilés F., et al. Favorable effects of hyperosmotic reperfusion on myocardial edema and infarct size. Am J Physiol 262 (1992) H17-H22
11. Inserte J., García-Dorado D., Hernando V., and Soler-Soler J. Calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion contributes to cell death after myocardial ischemia. Circ Res 97 (2005) 465-473
12. Inserte J., García-Dorado D., Hernando V., Barba I., and Soler-Soler J. Ischemic preconditioning prevents calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion. Cardiovasc Res 70 (2006) 364-373
13. Inserte J., García-Dorado D., Ruiz-Meana M., Agulló L., Pina P., and Soler-Soler J. Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. Cardiovasc Res 64 (2004) 105-114
14. Ruiz-Meana M., García-Dorado D., González M.A., Barrabés J.A., and Soler-Soler J. Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition. Cardiovasc Res 30 (1995) 64-69
15. Ruiz-Meana M., García-Dorado D., González M.A., Barrabés J.A., Oliveras J., and Soler-Soler J. Efecto del edema osmótico durante la reoxigenación sobre la viabilidad celular: Estudio en el miocito aislado. Rev Esp Cardiol 48 (1995) 266-271
16. García-Dorado D., Inserte J., Ruiz-Meana M., González M.A., Solares J., Juliá M., et al. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 96 (1997) 3579-3586
17. Rodríguez-Sinovas A., García-Dorado D., Ruiz-Meana M., and Soler-Soler J. Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium. J Physiol 559 (2004) 245-257
18. Rawanduzy A., Hansen A., Hansen T.W., and Nedergaard M. Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J Neurosurg 87 (1997) 916-920
19. Lin J.H., Weigel H., Cotrina M.L., Liu S., Bueno E., Hansen A.J., et al. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1 (1998) 494-500
20. Ruiz-Meana M., García-Dorado D., Hofstaetter B., Piper H.M., and Soler-Soler J. Propagation of cardiomyocyte hypercontracture by passage of Na(+) through gap junctions. Circ Res 85 (1999) 280-287
21. Abdallah Y., Gkatzoflia A., Pieper H., Zoga E., Walther S., Kasseckert S., et al. Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 66 (2005) 123-131
22. Siegmund B., Schlack W., Ladilov Y.V., Balser C., and Piper H.M. Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. Circulation 96 (1997) 4372-4379
23. Padilla F., García-Dorado D., Agullo L., Barrabés J.A., Inserte J., Escalona N., et al. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs. Cardiovasc Res 51 (2001) 592-600
24. Kitakaze M., Asakura M., Kim J., Shintani Y., Asanuma H., Hamasaki T., et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocadial infarction (J-WIND): two randomised trials. Lancet 370 (2007) 1483-1493
25. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434 (2005) 658-662
26. Halestrap A.P., and Brennerb C. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 10 (2003) 1507-1525
27. Duchen M.R., McGuinness O., Brown L.A., and Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 27 (1993) 1790-1794
28. Griffiths E.J., and Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307 (1995) 93-98
29. Di Lisa F., Menabo R., Canton M., Barile M., and Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276 (2001) 2571-2575
30. Honda H.M., Korge P., and Weiss J.N. Mitochondria and ischemia/reperfusion injury. Ann N Y Acad Sci 1047 (2005) 248-258
31. Vander Heide R.S., Angelo J.P., Altschuld R.A., and Ganote C.E. Energy dependence of contraction band formation in perfused hearts and isolated adult myocytes. Am J Pathol 125 (1986) 55-68
32. Ruiz-Meana M., Abellán A., Miró-Casas E., and García-Dorado D. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes. Basic Res Cardiol 102 (2007) 542-552
33. Barrabés J.A., García-Dorado D., Mirabet M., Inserte J., Agulló L., Soriano B., et al. Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia. J Am Coll Cardiol 45 (2005) 293-299
34. Mirabet M., García-Dorado D., Ruiz-Meana M., Barrabés J.A., and Soler-Soler J. Thrombin increases cardiomyocyte acute cell death after ischemia and reperfusion. J Mol Cell Cardiol 39 (2005) 277-283
35. Barrabés J.A., Mirabet M., Agulló L., Figueras J., Pizcueta P., and García-Dorado D. Platelet deposition in remote cardiac regions after coronary occlusion. Eur J Clin Invest 37 (2007) 939-946
36. Inserte J., García-Dorado D., Ruiz-Meana M., Solares J., and Soler J. The role of Na+-H+ exchange occurring during hypoxia in the genesis of reoxygenation-induced myocardial oedema. J Mol Cell Cardiol 29 (1997) 1167-1175
37. Rodríguez-Sinovas A., García-Dorado D., Padilla F., Inserte J., Barrabés J.A., Ruiz-Meana M., et al. Pre-treatment with the Na+/H+ exchange inhibitor cariporide delays cell-to-cell electrical uncoupling during myocardial ischemia. Cardiovasc Res 58 (2003) 109-117
38. Ruiz-Meana M., García-Dorado D., Julia M., Inserte J., Siegmund B., Ladilov Y., et al. Protective effect of HOE642, a selective blocker of Na+-H+ exchange, against the development of rigor contracture in rat ventricular myocytes. Exp Physiol 85 (2000) 17-25
39. García-Dorado D., González M.A., Barrabés J.A., Ruiz-Meana M., Solares J., Lidon R.M., et al. Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na(+)-H+ exchange. Cardiovasc Res 35 (1997) 80-89
40. Schäfer C., Ladilov Y.V., Siegmund B., and Piper H.M. Importance of bicarbonate transport for protection of cardiomyocytes against reoxygenation injury. Am J Physiol 278 (2000) H1457-H1463
41. Theroux P., Chaitman B.R., Danchin N., Erhardt L., Meinertz T., Schroeder J.S., et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation 102 (2000) 3032-3038
42. Zeymer U., Suryapranata H., Monassier J.P., Opolski G., Davies J., Rasmanis G., et al., ESCAMI Investigators. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 38 (2001) 1644-1650
43. The EXPEDITION Study Investigators. Effects of Na+/H+ exchange inhibition by cariporide on death and nonfatal myocardial infarction in patients undergoing coronary artery bypass graft surgery. The EXPEDITION study. Circulation. 2003;108:3M.
44. Flaherty J.T., Pitt B., Gruber J.W., Heuser R.R., Rothbaum D.A., Burwell L.R., et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 89 (1994) 1982-1991
45. Schafer C., Ladilov Y., Inserte J., Schafer M., Haffner S., García-Dorado D., et al. Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res 51 (2001) 241-250
46. Yamashita J., Kita S., Iwamoto T., Ogata M., Takaoka M., Tazawa N., et al. Attenuation of ischemia/reperfusion-induced renal injury in mice deficient in Na+/Ca2+ exchanger. J Pharmacol Exp Ther 304 (2003) 284-293
47. Agullo L., García-Dorado D., Escalona N., Ruiz-Meana M., Inserte J., and Soler-Soler J. Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes. Am J Physiol 284 (2003) H2170-H2176
48. Hempel A.M., Friedrich M., Schlüter K.D., Forssmann W.G., Kuhn M., and Piper H.M. ANP protects against reoxygenation-induced hypercontracture in adult cardiomyocytes. Am J Physiol 273 (1997) 244-249
49. Padilla F., García-Dorado D., Agulló L., Inserte J., Paniagua A., Mirabet S., et al. L-arginine administration prevents reperfusion-induced cardiomyocytehypercontracture and reduces infarct size in the pig. Cardiovasc Res 46 (2000) 412-420
50. Inserte J., García-Dorado D., Agulló L., Paniagua A., and Soler-Soler J. Urodilatin limits acute reperfusion injury in the isolated rat heart. Cardiovasc Res 45 (2000) 351-359
51. O'Neill S.C., Miller L., Hinch R., and Eisner D.A. Interplay between SERCA and sarcolemmal Ca2+ efflux pathways controls spontaneous release of Ca2+ from the sarcoplasmic reticulum in rat ventricular myocytes. J Physiol 559 (2004) 121-128
52. De Mello W.C. Atrial natriuretic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP. J Cardiovasc Pharmacol 32 (1998) 75-79
53. Hayashi M., Tsutamoto T., Wada A., Maeda K., Mabuchi N., Tsutsui T., Horie H., et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 37 (2001) 1820-1826
54. Kitakaze M., Asakura M., Kim J., Shintani Y., Asanuma H., Hamasaki T., et al., J-WIND investigators. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 370 (2007) 1483-1493
55. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359 (2008) 473-481
56. Staat P., Rioufol G., Piot C., Cottin Y., Cung T.T., L'Huillier I., et al. Postconditioning the human heart. Circulation 112 (2005) 2143-2148
57. Kirschner M.W. The meaning of systems biology. Cell 121 (2005) 503-504
58. Barba I., De León G., Martín E., Cuevas A., Aguade S., Candell-Riera J., et al. Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med 60 (2008) 27-32